Skip to main content

Table 1 Demographics, predisposing factors to infection and infectious history

From: Clinicopathologic features of infection-related glomerulonephritis with IgA deposits: a French Nationwide study

Variablesn = 27
Male (n (%))23 (85.2)
Age, year (mean ± SD)62 ± 15
Comorbid conditions
 Diabetes mellitus (n (%))12/27 (44.4)
 Hypertension (n (%))18/26 (69.2)
 Cardiovascular disease (n (%))13/25 (52.0)
 Active or former smokers (n (%))11/25 (44.0)
 Alcoholism (n (%))9/24 (37.5)
 Liver cirrhosis (n (%))2/22 (9.1)
 Immunosuppressive drug (n (%))1/27 (3.7)
Infectious agent
Staphylococcus (n (%))21 (77.8)
  MRSA (n (%))4 (14.8)
  MSSA (n (%))16 (59.3)
Staphylococcus haemolyticus (n (%))1 (3.7)
Morganella morganii (n (%))2 (7.4)
Streptococcus oralis (n (%))1 (3.7)
ESBL-producing Escherichia coli (n (%))1 (3.7)
Enterococcus faecalis (n (%))1 (3.7)
Enterobacteraerogenes (n (%))1 (3.7)
Chlamydia pneumoniae (n (%))1 (3.7)
Corynebacterium amycolatum (n (%))1 (3.7)
Dermabacter hominis (n (%))1 (3.7)
  More than one pathogen (n (%))7 (25.9)
  Unknown (n (%))3 (11.1)
Sites of infection
 Bone and joint infection (n (%))12 (44.4)
 Skin infection (n (%))11 (40.7)
 Bacteremia (n (%))11 (40.7)
 Other sites 
  Prosthesis, plate osteosynthesis or implantable venous access port (n (%))5 (18.5)
  Endocarditis (n (%))4 (14.8)
  Pneumonia (n (%))4 (14.8)
  Urinary tract infection (n (%))3 (11.1)
  1. Abbreviations: ESBL extended-spectrum beta-lactamases, MRSA methicillin-resistant Staphylococcus aureus, MSSA methicillin-sensitive Staphylococcus aureus, standard deviation